Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak Medical Dialogues Bureau27 Feb 2020 3:00 PM ISTState Governments and UTs are requested to closely monitor the production and availability of APIs and their formulations to prevent black marketing...
Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol Medical Dialogues Bureau27 Feb 2020 2:02 PM ISTAvailable in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West...
USFDA inspection at Cipla manufacturing facility in Goa, warning letter issued Medical Dialogues Bureau27 Feb 2020 1:56 PM ISTNew Delhi: Drug firm Cipla recently announced that it has received a warning letter from USFDA for its goa Manufacturing Facility.Pursuant to...
APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01 Medical Dialogues Bureau27 Feb 2020 10:00 AM ISTVienna: APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, has...
COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies Medical Dialogues Bureau27 Feb 2020 9:00 AM ISTWuXi Biologics will conduct cell-line development, process and formulation development, if the antibodies receive regulatory approvals, WuXi Biologics...
Sanofi plans to create standalone company dedicated to making APIs Medical Dialogues Bureau26 Feb 2020 3:37 PM ISTPARIS : Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically...
Lupin launches Ethacrynic Acid Tablets USP, 25 mg Medical Dialogues Bureau26 Feb 2020 3:27 PM ISTThe product would be manufactured at Lupin's Nagpur OSD facility, India.
Gilead's drug leads global race to find virus treatment Medical Dialogues Bureau26 Feb 2020 2:24 PM ISTBeijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh Medical Dialogues Bureau25 Feb 2020 4:28 PM ISTBeximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
FDA authorizes marketing of the first genetic test for Fragile X Syndrome Medical Dialogues Bureau25 Feb 2020 2:09 PM ISTUS: The U.S. Food and Drug Administration has authorized marketing of the test to detect a genetic condition known as Fragile X Syndrome (FXS), the...
Novartis announces FDA and EMA filing acceptance of ofatumumab, for treatment of relapsing form of MS Medical Dialogues Bureau25 Feb 2020 1:03 PM IST"With ofatumumab, we underpin our relentless dedication to reimagining medicine for patients across the MS spectrum and will work closely with the...
BA/BE study applications have to be processed in 15 days: CDSCO Medical Dialogues Bureau25 Feb 2020 12:50 PM ISTNew Delhi: In order to streamline the applications process by various pharma companies, the CDSCO in its notice has recently mandated that BA/BE...
